Several clinical trials are evaluating the potential use of SMO inhibitors for a variety of cancer treatments including Cyclopamine, Saridegib, Vismodegib, Cur61414, XL-139, and Sonidegib [197,198,199,200,201]. Here, SMO is linked to cancer.